Oxford Wealth Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-46,826	Closed	-$309K	–	60
2024 Q3	$309K	Sell	46,826 -655	-1%	-$4.32K	0.25%	52
2024 Q2	$356K	Buy	47,481 +36,841	+346%	+$276K	0.24%	49
2024 Q1	$106K	Buy	+10,640	New	+$106K	0.1%	60